BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$80.91 USD
-1.26 (-1.53%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $80.92 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Earnings News For BMRN
-
BioMarin (BMRN) Beats on Q1 Earnings, Voxzogo Drives Sales
-
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates
-
BioMarin: Q1 Earnings Snapshot
-
BioMarin Reports Record Financial Results for the First Quarter 2024
-
BioMarin Pharmaceutical (BMRN) Expected to Beat Earnings Estimates: Should You Buy?
-
BioMarin (BMRN) Posts Q4 Earnings Beat, Upbeat Voxzogo Sales
-
BioMarin: Q4 Earnings Snapshot
-
BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings and Revenue Estimates
-
BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024
-
BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: Should You Buy?
-
Why Is BioMarin (BMRN) Up 14.3% Since Last Earnings Report?
-
BioMarin (BMRN) Q3 Earnings in Line, Sales Miss, '23 View Cut
-
BioMarin: Q3 Earnings Snapshot
-
BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth
-
BioMarin (BMRN) Q2 Earnings & Sales Top, Voxzogo Drives Sales
-
BioMarin Pharmaceutical (BMRN) Tops Q2 Earnings and Revenue Estimates
-
BioMarin: Q2 Earnings Snapshot
-
Why Is BioMarin (BMRN) Down 4% Since Last Earnings Report?
-
BioMarin (BMRN) Q1 Earnings Top, Voxzogo Drives Sales
-
BioMarin Pharmaceutical (BMRN) Q1 Earnings and Revenues Surpass Estimates
-
BioMarin: Q1 Earnings Snapshot
-
BioMarin (BMRN) Q4 Earnings Miss, Sales Beat, Stock Down
-
BioMarin: Q4 Earnings Snapshot
-
BioMarin Pharmaceutical (BMRN) Q4 Earnings Lag Estimates
-
BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth